LD-Oncologic SRL
The score of LD-Oncologic shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +98 % Total assets +174 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LD-Oncologic's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 39,623 € | ||||
| Equity | 140,314 € | ||||
| Cash | 39,475 € | ||||
| EBITDA | 67,699 € | ||||
| Total assets | 268,450 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
LD-Oncologic's financial analysis
- Solvency52.3%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LD-Oncologic
LD-Oncologic's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0533.702.512
- VAT number
- BE0533702512
- Peppol
- Registered · 0208:0533702512 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Apr 2013
- Registered office
- 5520 Onhaye
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
LD-Oncologic (SRL) has been based in Onhaye since 2013, active in: medical specialists activities. For 2025, it reports a net profit of 39,623 € and equity of 140,314 €; its revenue is not published. Its solvency stands at 52.3%, below the median of its sector (65.0%).
Companies similar to LD-Oncologic
Companies in the same business, of comparable size and area, outside its group.
- IUS Soli Manufacture of basic pharmaceutical products Woluwe-Saint-Pierre · balance sheet 268,429 €
- Willems Engineering Manufacture of electrical and electronic equipment for motor vehicles Asse · balance sheet 268,128 €
- IDA-Foods Tongeren-Borgloon · balance sheet 268,410 €
- Immo Pont 9 Uccle · balance sheet 268,456 €
- M.V.D. Immo Herstal · balance sheet 268,406 €
- Immobiliere Foch Saint-Ghislain · balance sheet 268,549 €
- Gaelle Huon Medecine Physique ET Readaptation Forest · balance sheet 268,570 €
Frequently asked questions about LD-Oncologic
What is the revenue of LD-Oncologic?
LD-Oncologic files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LD-Oncologic?
In Belgium, the VAT number is the company number prefixed with BE: BE0533702512 for LD-Oncologic, if the company is VAT-registered. Its company number (CBE) is 0533.702.512.
Where is the registered office of LD-Oncologic?
According to the CBE register, the registered office of LD-Oncologic is in 5520 Onhaye.
What is the equity of LD-Oncologic?
At the close of the 2025 financial year, the equity of LD-Oncologic amounts to 140,314 €, a solvency of 52.3% of total assets.
Who manages LD-Oncologic?
The register lists 2 active mandates at LD-Oncologic. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LD-Oncologic
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →